InsiderSignal.AI

InsiderSignal.ai

PEPG - Pepgen Inc.

Insider Purchase by Oxford Science Enterprises Plc (Former 10% Owner)

6 Months
After Trade
Before Trade

Loading data...

Trade Summary

4 months ago, Oxford Science Enterprises Plc, serving as Former 10% owner Owner at Pepgen Inc. (PEPG), purchased 200,000 shares at $3.20 per share, for a total transaction value of $640,000.00. Following this transaction, Oxford Science Enterprises Plc now holds 4,955,388 shares of PEPG.

This purchase represents a 4.00% increase in Oxford Science Enterprises Plc's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, September 30, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, October 1, 2025, 1 day after the trade was made.

Pepgen Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Oxford Science Enterprises Plc

Former 10% Owner

Oxford Science Enterprises Plc (OSE) is a British early-stage venture capital firm and public limited company (company number 09093331) incorporated on 19 June 2014, headquartered at 46 Woodstock Road, Oxford, OX2 6HT, UK[[1]](https://en.wikipedia.org/wiki/Oxford_Science_Enterprises)[[3]](https://find-and-update.company-information.service.gov.uk/company/09093331). Originally founded as Oxford Sciences Innovation Plc in 2015 by David Norwood, it rebranded to its current name and manages over $800 million in assets under management (AUM), focusing on commercializing academic research from the University of Oxford through spin-out companies[[1]](https://en.wikipedia.org/wiki/Oxford_Science_Enterprises)[[2]](https://www.oxfordscienceenterprises.com)[[3]](https://find-and-update.company-information.service.gov.uk/company/09093331). OSE operates as an evergreen patient capital investor in deep tech and health tech sectors, partnering closely with Oxford University Innovation to manage intellectual property and build transformational businesses, with the university holding a shareholder stake[[1]](https://en.wikipedia.org/wiki/Oxford_Science_Enterprises)[[2]](https://www.oxfordscienceenterprises.com). Its leadership includes CEO Ed Bussey (appointed September 2023) and CIO Jack Edmondson; notable past leaders include Alexis Dormandy and Charles Conn[[1]](https://en.wikipedia.org/wiki/Oxford_Science_Enterprises). Backed by investors like Google Ventures, Sequoia Capital, and Huawei, OSE has driven significant growth in Oxford's science ecosystem, increasing spin-out investments from £125m annually (2011-2015) to £1.4bn in 2021[[1]](https://en.wikipedia.org/wiki/Oxford_Science_Enterprises)[[2]](https://www.oxfordscienceenterprises.com). As a former 10% owner of Pepgen Inc. (PEPG), it exemplifies its role in life sciences investments[search context].

View full insider profile →

Trade Price

$3.20

Quantity

200,000

Total Value

$640,000.00

Shares Owned

4,955,388

Trade Date

Tuesday, September 30, 2025

145 days ago

SEC Filing Date

Wednesday, October 1, 2025

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Pepgen Inc.

Company Overview

No company information available
View news mentioning PEPG

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/575020

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime